Koru announces pact for next-gen subcutaneous immunoglobulin infusion system
Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...
drugdeliverybusiness3d
Koru Medical inks deal to develop next-gen subcutaneous infusion system
Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.
Oregon health Q&A: Why isn’t wastewater reporting up to date for viruses?
A data point is marked as “insufficient data” if wastewater samples test negative for a virus (because levels are too low to ...
Pharmabiz13h
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...
uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
CSL Limited (OTC:CSLLY) and uniQure Inc (NASDAQ:QURE) announced the four-year results from the pivotal HOPE-B study ...
Endocrinology Advisor20h
Enhertu Approved for HR+, HER2-Low/Ultralow Metastatic Breast Cancer
Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.
News On Alternative Monoclonal Antibody For Treatment Of COVID-19 Spikes Invivyd, Inc. (Nasdaq: IVVD) To Top Gainer List
The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...